Type 2 diabetes drug could be beneficial for head and neck cancer patients
Saturday, June 4, 2016 - 19:00
in Health & Medicine
Researchers have found that adding increasing doses of an approved Type 2 diabetes drug, metformin, to a chemotherapy and radiation treatment regimen in head and neck cancer patients is not well tolerated if escalated too quickly, but allowing slower escalation could be beneficial.